.png)
German (DE) 
English (US) 
Spanish (ES) 
French (FR) 
Hindi (IN) 
Italian (IT) 
Russian (RU) - Health
- Parenting
- Style and beauty
- Horoscopes
- Shopping
- Food
- Travel
- Autos
- Gift ideas
- Buying guides
- Amazon Spring Sale
- Amazon tech sales
- My Portfolio
- News
- Markets
- Stocks: Most Actives
- Stocks: Gainers
- Stocks: Losers
- Trending Tickers
- Futures
- World Indices
- US Treasury Bonds Rates
- Currencies
- Crypto
- Top ETFs
- Top Mutual Funds
- Options: Highest Open Interest
- Options: Highest Implied Volatility
- Sectors
- Basic Materials
- Communication Services
- Consumer Cyclical
- Consumer Defensive
- Energy
- Financial Services
- Healthcare
- Industrials
- Real Estate
- Technology
- Utilities
- Private Companies
- Research
- Personal Finance
- Videos
- Streaming Now
New on Yahoo
New on Yahoo
© 2025 All rights reserved.
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Argus upgrades Integra to Buy, says well-positioned for a turnaround
TipRanks
Tue, Apr 1, 2025, 9:05 AM 1 min read
In This Article:
Argus analyst David Toung upgraded Integra LifeSciences (IART) to Buy from Hold with a $28 price target The firm sees the company as well-positioned for a turnaround, and with supply issues for Integra Skin products resolved, the company now expects sequentially stronger top and bottom-line growth as 2025 progresses. Argus also expects that under the leadership of new CEO Mojdeh Poul, the company will improve operations and sales execution in order tot meet demand for its reconstructive and neurosurgery products.
Don't Miss Our End of Quarter Offers:
-
Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks.
-
Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IART:
Terms and Privacy Policy
Comments